Am I permitted to drive with a cardiovascular condition?
Having a cardiovascular condition does not automatically mean you cannot hold a Group 2 licence. Whether you are permitted to drive depends on:
- the type and severity of the condition
- whether symptoms are stable and controlled
- the risk of sudden incapacity while driving
- whether you have recently had treatment, surgery, or hospital admission
Decisions are based on your current fitness to drive, overall risk, and the specific cardiac condition you have been diagnosed with.
When you are more likely to be permitted to drive
You are more likely to remain eligible to drive if your condition is:
- stable
- well-controlled
- fully assessed by a specialist
- not causing chest pain, fainting, dizziness, or blackouts
and you:
- are under appropriate medical follow-up
- are taking prescribed treatment and medication
- have no symptoms that affect awareness, judgement, or alertness while driving
In many cases, drivers continue working with periodic review or time-limited licensing rather than permanent refusal.
Situations where driving may be paused or restricted
Driving is usually stopped temporarily and, in some cases, permanently if there is:
- recent or unexplained chest pain or angina symptoms
- a recent heart attack or acute cardiac event
- uncontrolled or severe heart rhythm disturbances
- heart failure with significant symptoms
- collapse, blackout, or unexplained loss of consciousness
- pending investigations where risk has not yet been confirmed
In these situations, your licence is usually revoked. Relicensing may only be considered once:
- Assessment and treatment have been completed
- You have medical clearance
- Any required cardiac tests (such as an exercise tolerance test and echocardiogram) are satisfactory
- And there are no other disqualifying complications
Drivers Who Have Had a Recent Cardiac Surgery or Procedure
Driving must pause, DVLA notification is a must, and the license will be revoked for a defined recovery period after such procedures for example:
- coronary angioplasty or stent insertion (minimum 6 weeks)
- coronary artery bypass surgery (minimum 12 weeks)
- pacemaker implantation(minimum 6 weeks)
- Successful catheter ablation (driving restriction typically ranges from 2 to 12 weeks, depending on the type of arrhythmia being treated)
Return to driving usually depends on:
- recovery progress
- stability of symptoms
- consultant review
- confirmation of fitness to drive
Many Group 2 drivers may resume driving following a structured reassessment.
Medical Evidence the DVLA Usually Requires for a Relicensing Application
- Functional testing reports (e.g., exercise tolerance test)
- Cardiac imaging reports (e.g., echocardiogram, myocardial perfusion scan)
- Cardiology opinion
These investigations/reports are usually commissioned by the DVLA, and the cost is normally covered by them
Practical examples
Stable coronary disease
Past heart attack, currently symptom-free, and has successfully completed a 9-minute exercise treadmill test within the last 3 years.
Outcome: often permitted to continue driving, with a repeat of ETT every 3 years.
New unexplained chest pain
Symptoms are under investigation, and the cause is not yet known.
Outcome: Depending on the suspected cause and the advice of the treating healthcare professional. If a cardiac cause is suspected, driving will likely be stopped, and the DVLA may suspend the licence pending completion of investigations.
Pacemaker fitted, recovery completed
Symptoms resolved and no complications following implantation.
Outcome: driving may resume once medically cleared after the recovery period usually 6 weeks.
Key Takeaway
A cardiovascular condition does not automatically prevent Group 2 driving.
Licensing decisions are typically based on:
- stability of the condition
- likelihood of sudden incapacity
- recovery after recent treatment
- whether symptoms affect safe driving performance
Whilst driving may be permanently ceased in some cases, many drivers can return to driving Group 2 vehicles following appropriate assessment and cardiac review.